Physician profile
John Wagner
NPI 1336121870
$933.19
in general payments reported to CMS, 2019-2025
15 companies · $71.15 in 2025
The $71.15 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.66 · 2020: $12.65 · 2021: $98.67 · 2022: $178 · 2023: $378 · 2024: $165 · 2025: $71.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $279.54 | 2019-2025 | Acessa Provu System, Novasure, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $143.77 | 2023-2025 | |
| Abbvie INC. | $82.23 | 2022-2023 | Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $81.28 | 2023-2024 | Veozah |
| Coopersurgical, INC. | $70.07 | 2019-2023 | Paragard T 380a |
| Mayne Pharma Commercial LLC | $64.17 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $40.10 | 2023 | Myfembree |
| Shield Therapeutics INC | $35.59 | 2022 | |
| Baxter Healthcare | $27.38 | 2024 | Perclot |
| Exeltis, USA INC. | $27.18 | 2023 | Slynd |
| Exact Sciences Corporation | $20.84 | 2024 | Cologuard Collection Kit |
| Biogen, INC. | $17.77 | 2025 | Zurzuvae |
| Avanos Medical | $16.43 | 2023 | On-Q* Pump and Accessories |
| Myovant Sciences INC. | $14.20 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $12.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.